Back to Trades
Grant4
Elevance Health, Inc.
ELV
Total Value
$3.6M
Company Information
- Company Name
- Elevance Health, Inc.
- Ticker Symbol
- ELV
- CIK
- 0001156039
Insider Information
- Name
- Wessling Erin M
- Role
- EVP & Chief Legal Officer
- Location
- INDIANAPOLIS, IN
Officer
Filing Details
- Filing Date
- Mar 4, 2026
- Transaction Date
- Mar 2, 2026
- Accession Number
- 0002084548-26-000002
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Common Stock | 2,976 | — | Grant/Award | — |
| Mar 3, 2026 | Common Stock | 417 | $284.03 | Tax Withholding | $118.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Derivative | 11,754 | $294.07 | Grant/Award | $3.5M |
Footnotes
- (F1)Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
- (F2)PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- (F3)The option represents a right to purchase a total of 11,754 shares, and is exercisable in three annual installments, each installment of 3,918 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.